Advertisement
Advertisement
U.S. Markets open in 6 hrs 46 mins
S&P Futures
3,915.25 -1.00 (-0.03%) Dow Futures
31,480.00 -7.00 (-0.02%) Nasdaq Futures
12,139.25 -1.25 (-0.01%) Russell 2000 Futures
1,761.60 -0.10 (-0.01%) Crude Oil
107.47 -0.15 (-0.14%) Gold
1,838.70 +8.40 (+0.46%)
American Funds 2060 Target Date Retirement Fund Class R-5E (RHKTX)
Nasdaq - Nasdaq Delayed Price. Currency in USD
Add to watchlist
At close: 08:00PM EDT
Advertisement
| Previous Close | 13.85 |
| YTD Return | -8.84% |
| Expense Ratio (net) | 0.55% |
| Category | Target-Date 2060+ |
| Last Cap Gain | 0.00 |
| Morningstar Rating | ★★★★★ |
| Morningstar Risk Rating | Below Average |
| Sustainability Rating |
| Net Assets | 5.19B |
| Beta (5Y Monthly) | 1.38 |
| Yield | 0.66% |
| 5y Average Return | N/A |
| Holdings Turnover | 3.00% |
| Last Dividend | 0.01 |
| Average for Category | N/A |
| Inception Date | Nov 20, 2015 |
- GlobeNewswire
Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022
Live Conference Call and Webcast at 4:30 p.m. ETPRINCETON, N.J., May 03, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2022 financial results after the market close on Thursday, May 12, 2022. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update. DateThursday, May 12, 2022Time4:30 p.m. ETW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
